ConductScience.org, home

Paper7004534

Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression.

Sullivan KM and 8 others. Blood, 1981. Cited by 895 papers, by iCite.

Cite this record

ConductScience Library. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Papers, record 7004534. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7004534

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression.
PubMed
Journal
Blood
PubMed
Year
1981
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
895
iCite
Relative citation ratio, by iCite
29.3
iCite
Revised in PubMed
2021-02-16
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sullivan KMK M
2Shulman HMH M
3Storb RR
4Weiden PLP L
5Witherspoon RPR P
6McDonald GBG B
7Schubert MMM M
8Atkinson KK
9Thomas EDE D

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antilymphocyte SerumMajor topic
AzathioprineMajor topic
Graft vs Host ReactionMajor topic
PrednisoneMajor topic
Bone Marrow Transplantation
Chronic Disease
Drug Therapy, Combination
Follow-Up Studies
Humans
Transplantation, Homologous

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA 15704NCI NIH HHSUnited StatesP01CA015704PubMed and NIHNIH RePORTER
CA 18029NCI NIH HHSUnited StatesP01CA018029PubMed and NIHNIH RePORTER
CA 18221NCI NIH HHSUnited StatesP01CA018221PubMed and NIHNIH RePORTER
P30CA015704NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT02701517Cyclosporine Plus Methotrexate or AlemtuzumabBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by216

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 895 citations.

PMIDTitleJournalYearIn PapersSource
42931992Post-transplant monitoring of NGS-based measurable residual disease and donor chimerism as a prognostic tool in older patients with AML/MDS.Blood Res2026https://conductscience.org/library/papers/42931992PubMed
42401707CHIME: a novel HLA eplet model associates with non-relapse mortality in haploidentical hematopoietic cell transplant with post-transplant cyclophosphamide.Bone Marrow Transplant2026https://conductscience.org/library/papers/42401707PubMed
42150590
Total marrow and lymphoid irradiation in combination with cyclophosphamide and etoposide before haematopoietic cell transplantation for relapsed or refractory acute leukaemia: a single-centre, open-label, phase 2 trial.
Lancet Haematol2026https://conductscience.org/library/papers/42150590PubMed
42037753Steroid-Refractory Chronic Graft-Versus-Host Disease-Associated Isolated Myositis Successfully Treated With Ruxolitinib: A Case Report.EJHaem2026https://conductscience.org/library/papers/42037753PubMed
41846916Evaluation of cyclophosphamide for steroid-refractory hepatic acute graft-vs-host disease after allogeneic hematopoietic stem cell transplantation.Front Immunol2026https://conductscience.org/library/papers/41846916PubMed
41046057Umbilical Cord Blood Transplantation Provides an Alternative for Patients With Chronic Granulomatous Disease Lacking HLA-Matched Donors: A PIDTC Report.Transplant Cell Ther2026https://conductscience.org/library/papers/41046057PubMed
40236695Case Report: Diagnosis and successful treatment of a rare case of steroid-refractory chronic graft-vs-host disease-related serositis.Front Immunol2025https://conductscience.org/library/papers/40236695PubMed
40175657Influence of pre-transplant estimated glomerular filtration rate (eGFR) on clinical outcomes after allogeneic hematopoietic cell transplantation.Bone Marrow Transplant2025https://conductscience.org/library/papers/40175657PubMed
38776400Racial, ethnic, and socioeconomic diversity and outcomes of patients with graft-versus-host disease: a CIBMTR analysis.Blood Adv2024https://conductscience.org/library/papers/38776400PubMed
38534941Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development.Curr Oncol2024https://conductscience.org/library/papers/38534941PubMed
37906445The delicate balance of graft versus leukemia and graft versus host disease after allogeneic hematopoietic stem cell transplantation.Expert Rev Hematol2023https://conductscience.org/library/papers/37906445PubMed
37844687Severity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancy.Transplant Cell Ther2024https://conductscience.org/library/papers/37844687PubMed
37562003Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD.Blood2023https://conductscience.org/library/papers/37562003PubMed
37089776Association Between Candidemia and Noninfectious Interstitial Pneumonia After Allogeneic Hematopoietic Cell Transplantation: JSTCT Transplant Complications Working Group.Open Forum Infect Dis2023https://conductscience.org/library/papers/37089776PubMed
36979928Rapamycin Treatment Alleviates Chronic GVHD-Induced Lupus Nephritis in Mice by Recovering IL-2 Production and Regulatory T Cells While Inhibiting Effector T Cells Activation.Biomedicines2023https://conductscience.org/library/papers/36979928PubMed
36779595Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis.Haematologica2023https://conductscience.org/library/papers/36779595PubMed
36572728Impact of standard-dose dipeptidyl peptidase-4 inhibitors on the incidence of graft-versus-host disease after allogeneic hematopoietic cell transplantation.Bone Marrow Transplant2023https://conductscience.org/library/papers/36572728PubMed
36450828First-line steroid-free systemic treatment of acute and chronic graft-versus-host disease after novel prophylaxis regimens.Bone Marrow Transplant2023https://conductscience.org/library/papers/36450828PubMed
36446899Steroid-free first line treatment of moderate and severe chronic GVHD: a survey from the Transplant Complications Working Party of the EBMT.Bone Marrow Transplant2023https://conductscience.org/library/papers/36446899PubMed
36195679
Improved survival after single-unit cord blood transplantation using fludarabine and melphalan-based reduced-intensity conditioning for malignant lymphoma: impact of melphalan dose and graft-versus-host disease prophylaxis with mycophenolate mofetil.
Ann Hematol2022https://conductscience.org/library/papers/36195679PubMed

See all 216 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7004534

GET https://conductscience.org/api/papers/v1/7004534/cited_by?page=2